Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure 1 from Trametinib Thwarts Activation of Survival Pathways Induced by Pro-ferroptotic Drug Conjugate ACXT-3102 Resulting in Enhanced Pancreatic Cancer Cell Death
  1. Home
  2. Publications
  3. Supplementary Figure 1 from Trametinib Thwarts Activation of Survival Pathways Induced by Pro-ferroptotic Drug Conjugate ACXT-3102 Resulting in Enhanced Pancreatic Cancer Cell Death

Supplementary Figure 1 from Trametinib Thwarts Activation of Survival Pathways Induced by Pro-ferroptotic Drug Conjugate ACXT-3102 Resulting in Enhanced Pancreatic Cancer Cell Death

Authors:
  • Kumar S. Bishnupuri
    Kumar S. Bishnupuri
  • KNKenneth F. Newcomer
    Kenneth F. Newcomer
  • QGQingqing Gong
    Qingqing Gong
  • RTRony Takchi
    Rony Takchi
  • LYLi Ye
    Li Ye
  • SVSuwanna Vangveravong
    Suwanna Vangveravong
  • LRLauren Ross
    Lauren Ross
  • Brian A. Van Tine
    Brian A. Van Tine
  • WHWilliam G. Hawkins
    William G. Hawkins
  • DSDirk Spitzer
    Dirk Spitzer

Open Access
Publisher website
Google Scholar
  • 2 December 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.30761260
Abstract
Cell viability assays exhibiting ferrostatin-1 and deferoxamine (ferroptosis-specific inhibitors)-mediated blocking of ACXT-3102-induced cell death in PDAC (BxPC-3, AsPC-1, and PANC-1) cells.
Keywords
  • GASTROINTESTINAL CANCERS
  • PANCREATIC CANCER
  • PRECLINICAL MODELS
  • XENOGRAFT MODELS
  • SMALL MOLECULE AGENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.